ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,788.86
-0.41%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.662
0.17%
Brent Oil
84.245
0.35%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. AMEX
  6. Brooklyn ImmunoTherapeutics Inc (BTX)

  7. Brooklyn ImmunoTherapeutics Inc (BTX) ニュース

BTX

Brooklyn ImmunoTherapeut... (BTX)

Brooklyn ImmunoTherapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:BTX
日付受信時刻ニュースソース見出しコード企業名
2023/05/1205 : 35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/1019 : 02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0520 : 02Edgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0520 : 02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0520 : 01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/05/0519 : 31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/2522 : 02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/2105 : 31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/1120 : 31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/0506 : 15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/04/0506 : 05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/03/2121 : 39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/03/0706 : 06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/01/2706 : 32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/01/1106 : 31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2023/01/0422 : 36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/2106 : 31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/1707 : 01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/1506 : 31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0708 : 52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0706 : 31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0607 : 21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0520 : 04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/12/0307 : 01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/11/2306 : 07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/11/1506 : 57Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/10/2505 : 32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/10/1505 : 34Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/10/1121 : 31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
2022/09/2405 : 32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:BTX

最近閲覧した銘柄

NYSE
CVX
Chevron
AMEX
SPY
SPDR S&P 500
FX
USDGBP
US Dollar vs Sterling
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AMZN
Amazon.com
FX
USDJPY
US Dollar vs Yen
COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
AMEX
XLV
Health Care Select Sector
FX
USDEUR
US Dollar vs Euro
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有